A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)

A Prospective, Observational, Quality Improvement Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02502695

Enrollment

173

Registered

2015-07-20

Start date

2015-06-30

Completion date

2019-05-31

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

VATS Lobectomy and Segmentectomy for Lung Cancer, Lung Cancer

Brief summary

This is a research study for participants who have been diagnosed with lung cancer and are receiving VATS (Video Assisted Thoracoscopic Surgery) lobectomy or segmentectomy. The overall objective of this study is to develop a database to collect data on participants who are undergoing VATS lobectomy or segmentectomy for lung cancer.

Detailed description

This database will be used as for quality improvement purposes. Furthermore, the database will help in collecting data in an organized fashion, which will help the investigators learn more about the details of the workup performed prior to the surgery, during the surgery, peri-operative management and early follow-up. The investigators hope that this database will help to determine a common guideline to perform VATS lobectomy or segmentectomy. By creating a common guideline for future treatment of VATS patients, the investigators predict the efficiency of the process will increase significantly without decreasing, and perhaps even improving, the quality of the procedure.

Interventions

OTHERVATS-associated best practices

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Male and female subjects * Age ≥ 18 years * Underwent a VATS lobectomy or segmentectomy procedure for lung cancer -- Note: patients with other malignancies are eligible if they have a primary cancer of the lung as defined above

Exclusion criteria

* Subjects undergoing thoracotomy lobectomy or segmentectomy for lung cancer * Subjects undergoing surgical procedures other than VATS lobectomy or segmentectomy for lung cancer

Design outcomes

Primary

Measure	Time frame
Total inpatient cost	30 Days
Readmissions rates within 30 days of the patient's surgery date	30 Days
Incidence of post-operative complications within 30 days of the patient's surgery date	30 Days

Secondary

Measure	Time frame	Description
Difference in readmission rates between the two cohorts	3 years	To compare current VATS-associated procedures with a set of best VATS-associated practives implemented across the participating study centers

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026